Clinical trial
Short-Term Endogenous Hydrogen Sulfide Upregulation
NCT03303534 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Short-Term Endogenous Hydrogen Sulfide Upregulation
- Lead sponsor
- Brigham and Women's Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 14, 2017
- Completion date
- June 1, 2018
- Enrollment
- 9 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
caloric restriction, carotid stenosis